These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

85 related articles for article (PubMed ID: 12187753)

  • 1. [Management of gastrointestinal mucosal damage in patients with cerebrovascular disease].
    Kawakubo K; Fujishima M
    Nihon Rinsho; 2002 Aug; 60(8):1573-9. PubMed ID: 12187753
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Non-steroidal anti-inflammatory drug gastropathy: clinical results with H2 antagonists and proton pump inhibitors.
    Lazzaroni M; Bianchi Porro G
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S73-8. PubMed ID: 10379473
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Antisecretory therapy as a component of hemostasis in acute gastroduodenal ulcer bleedings].
    Gostishchev VK; Evseev MA
    Khirurgiia (Mosk); 2005; (8):52-7. PubMed ID: 16091681
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proton-pump inhibitors reduce the risk of uncomplicated peptic ulcer in elderly either acute or chronic users of aspirin/non-steroidal anti-inflammatory drugs.
    Pilotto A; Franceschi M; Leandro G; Paris F; Cascavilla L; Longo MG; Niro V; Andriulli A; Scarcelli C; Di Mario F
    Aliment Pharmacol Ther; 2004 Nov; 20(10):1091-7. PubMed ID: 15569111
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A prospective randomized trial of either famotidine or omeprazole for the prevention of bleeding after endoscopic mucosal resection and the healing of endoscopic mucosal resection-induced ulceration.
    Yamaguchi Y; Katsumi N; Tauchi M; Toki M; Nakamura K; Aoki K; Morita Y; Miura M; Morozumi K; Ishida H; Takahashi S
    Aliment Pharmacol Ther; 2005 Jun; 21 Suppl 2():111-5. PubMed ID: 15943857
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Review article: prevention of non-steroidal anti-inflammatory drug gastrointestinal complications--review and recommendations based on risk assessment.
    Chan FK; Graham DY
    Aliment Pharmacol Ther; 2004 May; 19(10):1051-61. PubMed ID: 15142194
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevention of NSAID-gastropathy.
    Ardizzone S; Bianchi Porro G
    Ital J Gastroenterol; 1996 Dec; 28 Suppl 4():33-6. PubMed ID: 9032581
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention and treatment of stress ulcers in critically ill patients.
    Yang YX; Lewis JD
    Semin Gastrointest Dis; 2003 Jan; 14(1):11-9. PubMed ID: 12610850
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prevention and treatment of non-steroidal anti-inflammatory drug-induced gastro-duodenal damage: rationale for the use of antisecretory compounds.
    Scarpignato C; Pelosini I
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S63-72. PubMed ID: 10379472
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological and pharmacodynamic essentials of H(2)-receptor antagonists and proton pump inhibitors for the practising physician.
    Huang JQ; Hunt RH
    Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):355-70. PubMed ID: 11403532
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Progress with proton pump inhibitors in acid peptic disease: treatment of duodenal and gastric ulcer.
    Florent C
    Clin Ther; 1993; 15 Suppl B():14-21. PubMed ID: 7911399
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Role of circadian rhythm and endogenous melatonin in pathogenesis of acute gastric bleeding erosions induced by stress.
    Brzozowski T; Zwirska-Korczala K; Konturek PC; Konturek SJ; Sliwowski Z; Pawlik M; Kwiecien S; Drozdowicz D; Mazurkiewicz-Janik M; Bielanski W; Pawlik WW
    J Physiol Pharmacol; 2007 Dec; 58 Suppl 6():53-64. PubMed ID: 18212400
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Recent progress in the drug therapy for gastrointestinal bleeding].
    Nakajima S; Bamba T
    Nihon Rinsho; 1998 Sep; 56(9):2291-6. PubMed ID: 9780708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Prevention and treatment of gastrointestinal symptoms and complications due to NSAIDs.
    McCarthy DM
    Best Pract Res Clin Gastroenterol; 2001 Oct; 15(5):755-73. PubMed ID: 11566039
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Role of acid suppressants in prophylaxis of NSAID damage.
    Chan FK; Sung JJ
    Best Pract Res Clin Gastroenterol; 2001 Jun; 15(3):433-45. PubMed ID: 11403537
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stress ulcer prophylaxis in critically ill patients: a randomized controlled trial.
    Kantorova I; Svoboda P; Scheer P; Doubek J; Rehorkova D; Bosakova H; Ochmann J
    Hepatogastroenterology; 2004; 51(57):757-61. PubMed ID: 15143910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Omeprazole to prevent recurrent bleeding after endoscopic treatment of ulcers.
    Libby ED
    N Engl J Med; 2000 Aug; 343(5):358-9. PubMed ID: 10922427
    [No Abstract]   [Full Text] [Related]  

  • 18. [Are proton pump inhibitors superior to H2 receptor antagonists within the scope of H. pylori eradication therapy? Meta analysis of current parallel group comparisons].
    Holtmann G; Layer P; Goebell H
    Z Gastroenterol; 1996 May; 34(5):267-72. PubMed ID: 8686357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A clinical approach to management of patients with non-steroidal anti-inflammatory gastropathy.
    Yeomans ND
    Ital J Gastroenterol Hepatol; 1999; 31 Suppl 1():S89-92. PubMed ID: 10379475
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Drug prevention and therapy of acute gastroduodenal lesions (stress ulcers)].
    von Ritter C
    Wien Med Wochenschr; 1992; 142(8-9):180-2. PubMed ID: 1354910
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.